Rocuronium Bromide

Rocuronium Bromide

Cat Number
API119302919
CAS Number
119302-91-9

If you have any other questions, please contact our experts.

CAS Number
119302-91-9
EINECS
601-597-6
Storage
Powder: -20℃; In solvent: -80℃ for 1 year
Synonyms
Zemuron Esmeron Rocuronium (Bromide) ORG 9426
Molecular Formula
C32H53BrN2O4
Molecular Weight
609.7
Smiles
CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-]
Appearance
Off-white or light yellow powder
Melting Point
161-169℃
General Description
Rocuronium bromide is a fast-onset, intermediate-acting, non-depolarizing neuromuscular blocking agent (NMBA). It is a synthetic quaternary aminosteroid compound, chemically designated as an analogue of pancuronium and vecuronium. Rocuronium is characterized by its rapid onset of action, which is the fastest of any currently available non-depolarizing muscle relaxant, making it a clinically useful alternative to succinylcholine in certain rapid sequence intubation (RSI) scenarios.
Mechanism of Action
Rocuronium produces its muscle relaxant effect by acting as a competitive antagonist at nicotinic cholinergic receptors located on the motor end-plate of skeletal muscle.
Application
Rocuronium bromide is indicated as an adjunct to general anesthesia to facilitate both routine and rapid sequence tracheal intubation, and to provide skeletal muscle relaxation during surgical procedures or mechanical ventilation in the intensive care unit (ICU).

Baek et al. reported that rocuronium bromide exerts differential regulatory effects on vascular endothelial cells, as demonstrated in cultured CPAE cells. Rocuronium bromide treatment suppressed endothelial nitric oxide synthase (eNOS) activity, leading to reduced nitric oxide (NO) production. Concurrently, the compound activated cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). This activation resulted in increased synthesis of prostaglandin E2 (PGE2).

Fig. 1 The effects of rocuronium bromide treatment on cyclooxygenase-1 (COX-1) in calf pulmonary artery endothelial (CPAE) cells. (Baek SB,  <i>et al</i>., 2016) Fig. 1 The effects of rocuronium bromide treatment on cyclooxygenase-1 (COX-1) in calf pulmonary artery endothelial (CPAE) cells. (Baek SB, et al., 2016)

References

  1. Baek SB, et al. Rocuronium Bromide Inhibits Inflammation and Pain by Suppressing Nitric Oxide Production and Enhancing Prostaglandin E2 Synthesis in Endothelial Cells. Int Neurourol J. 2016, 20(4):296-303.

Chompunud Na Ayudhya C, et al. demonstrated that rocuronium directly activates mast cell degranulation through distinct receptor pathways in mice and humans, providing the first evidence of MRGPRX2-mediated activation in human mast cells. In mouse peritoneal mast cells (PMCs), rocuronium (20 µg/mL) induced degranulation via MrgprB2, the murine ortholog of the human MRGPRX2 receptor. In human mast cells, degranulation required a higher concentration (≥500 µg/mL) and was mediated specifically through MRGPRX2. This study provides the first direct evidence that rocuronium induces degranulation in human mast cells through engagement of MRGPRX2.

Fig. 2 Rocuronium activates mouse peritoneal mast cells (PMCs) via MrgprB2. (Chompunud Na Ayudhya C, <i>et al</i>, 2021) Fig. 2 Rocuronium activates mouse peritoneal mast cells (PMCs) via MrgprB2. (Chompunud Na Ayudhya C, et al, 2021)

References

  1. Chompunud Na Ayudhya C, et al. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants. Cells. 2021, 10(1):156.

Does exposure to elevated temperatures accelerate impurity formation in Rocuronium Bromide?

Yes, Rocuronium Bromide is susceptible to temperature-related degradation. We conduct stress studies to map impurity formation, and our storage recommendations are designed to minimize this.

Is the Rocuronium Bromide packaging suitable for long-term storage in humid climates?

Absolutely. We use triple-layer, moisture-barrier foil bags with oxygen absorbers inside fiber drums specifically to protect Rocuronium Bromide from humidity during long-term storage in tropical zones.

What is the impurity profile specification for Rocuronium Bromide?

We specifically control for known process-related impurities and degradation products, ensuring they are kept to a minimum.

Can I request a customized certificate of analysis (CoA) for Rocuronium Bromide?

Yes, we can tailor the CoA format to include your specific batch number references or highlight particular pharmacopoeial tests required by your quality department.
You Might Also Like
Mepivacaine Hydrochloride
Mepivacaine Hydrochloride

Cat NO.: API1722629
CAS NO.: 1722-62-9

View Details
Ropivacaine Hydrochloride
Ropivacaine Hydrochloride

Cat NO.: API0232524
CAS NO.: 98717-15-8

View Details
Articaine Hydrochloride
Articaine Hydrochloride

Cat NO.: API23964570
CAS NO.: 23964-57-0

View Details
Ropivacaine HCL
Ropivacaine HCL

Cat NO.: API98717158
CAS NO.: 98717-15-8

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.

WhatsAPP
Top